Organization
Vinmec Research Institute of Stem Cell and Gene Technology
18 clinical trials
Clinical trial
A Phase I, Open-label Trial on the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cell Administration in the Management of Adult Liver CirrhosisStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
The Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis at Vinmec International HospitalStatus: Completed, Estimated PCD: 2019-06-30
Clinical trial
Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective StudyStatus: Completed, Estimated PCD: 2021-09-25
Clinical trial
Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae After Traumatic Brain InjuryStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type 2 DiabetesStatus: Completed, Estimated PCD: 2019-08-01
Clinical trial
Allogeneic Human Umbilical Cord-derived Mesenchymal Stem/Stromal Cells for Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a Matched Case-control, Phase I/II TrialStatus: Completed, Estimated PCD: 2021-07-30
Clinical trial
Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism InvestigationStatus: Active (not recruiting), Estimated PCD: 2023-04-20
Clinical trial
Evaluation of Autologous Adipose Derived Mesenchymal Stem Cells (AD-MSCs) Therapy on Sexual Hormone Deficiency in the Middle-aged Patients: an Open-label, Single-group Clinical TrialStatus: Completed, Estimated PCD: 2020-02-28
Clinical trial
Assessment of the Safety of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above IllnessStatus: Completed, Estimated PCD: 2021-03-30
Clinical trial
Evaluation of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Efficacy for the Treatment of Sexual Function Impairment in FemaleStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Phase I Clinical Trial Evaluating the Safety and Efficacy of Point-of-care CAR-T-cell Therapy in the Treatment of Relapsed/Refractory CD19+ Non-Hodgkin Lymphoma and Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
Outcomes of Umbilical Cord Blood-derived Mesenchymal Stem Cell Infusion in Patients With Neurological Complications After Ischemic StrokeStatus: Completed, Estimated PCD: 2022-12-30
Clinical trial
Outcomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary DysplasiaStatus: Completed, Estimated PCD: 2020-11-30
Clinical trial
Outcomes of Autologous Bone Marrow Mononuclear Stem Cell (BMMC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia After Kasai's Operation: An Open Label Uncontrolled Clinical TrialStatus: Completed, Estimated PCD: 2021-09-30
Clinical trial
Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Educational Intervention for Autism Spectrum Disorders (ASD): A Phase 2 Randomised Controlled TrialStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes TreatmentStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
Evaluation of the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency: A Phase I/IIa Randomised Crossover TrialStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Assessment of the Safety and Efficacy of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above IllnessStatus: Completed, Estimated PCD: 2021-06-30